P-15 Chronic myelomonocytic leukemia:IPSS best discriminates patients with worse prognosis, in both the dysplastic and the proliferative subtype
A.S. Symeonidis; V. Lambropoulou; E. Michalis; A. Chatzivassilis; A. Kouraklis; A. Galanopoulos; P. Matsouka; N. Anagnostopoulos; P. Iliakis; N. Zoumbos
- 作者A.S. Symeonidis; V. Lambropoulou; E. Michalis; A. Chatzivassilis; A. Kouraklis; A. Galanopoulos; P. Matsouka; N. Anagnostopoulos; P. Iliakis; N. Zoumbos
- 卷第29卷
- 印刷ISSN0145-2126
- 文件大小76.79KB
- 发表时间2005
- DOI10.1016/s0145-2126(05)80079-7